Company intelligence
Biological E. Limited
Celebrating Life Everyday
About Biological E. Limited
Biological E. Limited (BE), the first private sector biological products company in India and the first pharmaceuticals company in South India was established in 1953. Originally incorporated as Biological Products Private Limited, and launched by Dr. Vijay Kumar Datla, today, BE is a globally recognised vaccine manufacturer and has supplied over 2 Billion Doses of Vaccines till date all over the world. BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO, many global markets, and in India to the National Immunization Program, various State Governments, PSUs, Indian Armed Forces and the domestic retail market. With a mission to improve health and survival of people and contribute to the societies BE serves by providing equitable access to quality vaccines and therapeutics. BE has a long and richly textured history of supporting public health programs in India for over five decades. Our portfolio of WHO pre-qualified vaccines include the 5-in-1 Pentavalent and a Japanese Encephalitis vaccine and our future offerings promise to be even more exciting.
Verified activity
Signals from Biological E. Limited
12 published signals
Presence & Recognition
Biological E. Limited was honoured by the Pharmaceuticals Export Promotion Council of India for its contribution to India’s Pharmaceutical Exports during 2024–25.
Reported by Biological E. Limited
Presence & Recognition
Biological E. Limited launched BE Life Sciences in a new room with CEO Ripan Puri setting the direction for the new chapter.
Reported by Biological E. Limited
Presence & Recognition
Biological E. Limited received recognition from the entire team.
Reported by Manishkumar Munot
Presence & Recognition
Biological E. Limited received PHARMEXCIL recognition for its dedication to making quality healthcare accessible worldwide.
Reported by Marty Henehan
Strategy & Corporate Development
Biological E. Limited asked leaders shaping the journey of BE Life Sciences (BELS) to share their perspectives on the future of BELS.
Reported by Biological E. Limited
Strategy & Corporate Development
Biological E. Limited officially launched BE Life Sciences (BELS) marking the beginning of a new chapter for the pharmaceutical business.
Reported by Biological E. Limited
Presence & Recognition
Biological E. Limited shared that Kamal Kumar Upadhyay Ph.D has been invited to serve as a Moderator at the workshop “Navigating the GLP-1 Generic Drug Pathway,” organized by the Center for Research on Complex Generics (CRCG) on September 23–24, 2026, at The Universities at Shady Grove, Maryland.
Reported by Biological E. Limited
People
Biological E. Limited is hiring experienced and dynamic professionals for the Vaccine Business in Hyderabad, including roles in Production, Manufacturing, Quality, QC, and Engineering.
Reported by Biological E. Limited
Presence & Recognition
Biological E. Limited hosted a candid edition of Coffee with Leaders featuring Manishkumar Munot, BE’s Chief Business Officer, discussing leadership, growth, people, and the future.
Reported by Biological E. Limited
People
Biological E. Limited employee Markus Bergmann joined the company and started an exciting new chapter focused on healthcare innovation, including cell and gene therapies and RNA-based technologies.
Reported by Markus Bergmann
Presence & Recognition
Biological E. Limited attended CDMO Live Americas in Boston on Tuesday, October 20, moderating a roundtable discussion on pre-launch capacity planning and second sourcing.
Reported by Marty Henehan
Presence & Recognition
Biological E. Limited represented the company as an Invited Speaker and Panellist at the India Vaccine Leaders’ Conclave 2026 in Pune.
Reported by Biological E. Limited